Skip to content

Taryag Medical Ltd.

Israel IL-MF-000006979 Last updated 21 Oct 2026

Devices
4
Registries
EUDAMED
FDA recalls
0

Catalogue4

  • Bycross Ref BC213-135

    Class IIa EUDAMED Active

  • Bycross Ref BC213-50

    Class IIa EUDAMED Active

  • Bycross Ref BC213-95

    Class IIa EUDAMED Active

  • Bycross Ref BC213-70

    Class IIa EUDAMED Active

Related companies

Authorised representatives

About

Revolutionize care with Taryag's advanced PVD therapies. Explore cutting-edge solutions for superior Peripheral Vascular Disease treatment.

From the manufacturer's own website. Source

What Taryag Medical Ltd. makes

Taryag Medical Ltd. manufactures the BYCROSS device, which is used in the treatment of peripheral vascular disease.

The BYCROSS device is classified as Class IIa and is listed in the Eudamed registry. The company is based in Israel.

Written from this company's registered devices by an AI model, and not verified by a human reviewer.

Frequently asked questions

What types of medical devices does Taryag Medical Ltd. manufacture?

Taryag Medical Ltd. manufactures the BYCROSS device, which is designed for use in the treatment of peripheral vascular disease. This device represents the company's focus on providing therapeutic solutions for vascular conditions.

Where is Taryag Medical Ltd. located?

Taryag Medical Ltd. is based in Israel, which is indicated by the country code 'IL' in the regulatory data. This location serves as the company's base of operations for its medical device manufacturing activities.

In which regulatory registries are Taryag Medical Ltd.'s devices listed?

The BYCROSS device manufactured by Taryag Medical Ltd. is listed in the Eudamed registry, which is the European database for medical devices. This listing indicates that the device is registered for use within the European regulatory framework.

How are Taryag Medical Ltd.'s devices classified under medical device regulations?

The BYCROSS device is classified as Class IIa under medical device classification systems. This classification indicates that the device is of moderate risk and is subject to specific regulatory controls regarding its safety, performance, and quality assurance before it can be marketed.

AI-generated from registry data and not verified by a human reviewer.

Information

Country
Israel(from SRN)
Address
14, Ha’ilan Street, Or Akiva, Israel
Phone
+97246776929
PRRC contact
Malki Epel
EUDAMED SRN
IL-MF-000006979